Poor medication adherence in clinical trials: consequences and solutions
- Breckenridge, A
- Aronson, JK
- Blaschke, TF
- Hartman, D
- Peck, CC
- Vrijens, B
Publication date
February 2017
DOI Publisher
Springer Science and Business Media LLC Journal
Nature Reviews Drug DiscoveryAbstract
Poor adherence to medicines in clinical trials can undermine the value of the trials; for example, by compromising estimates of the benefits and risks of a medicine. In this article, we highlight such consequences and also discuss approaches to tackle this problem
Add to ORKG